Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence against a temporal association between cerebrovascular disease and Alzheimer’s disease imaging biomarkers

29 May 2023

Abstract excerpt

Abstract Whether a relationship exists between cerebrovascular disease and Alzheimer’s disease has been a source of controversy. Evaluation of the temporal progression of imaging biomarkers of these disease processes may inform mechanistic associations. We investigate the relationship of disease trajectories of cerebrovascular disease (white matter hyperintensity, WMH, and fractional anisotropy, FA) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Neuroimaging Techniques and Applications
Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37248223
DOI: 10.1038/s41467-023-38878-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence against a temporal association between cerebrovascular disease and Alzheimer’s disease imaging biomarkersPMID 37248223Read ↗

Vascular burden and Alzheimer disease pathologic progression.Semantic proximity Read ↗

The Temporal Relationships between White Matter Hyperintensities, Neurodegeneration, Amyloid β, and CognitionSemantic proximity Read ↗

Timing of changes in Alzheimer’s disease plasma biomarkers as assessed by amyloid and tau PET clocksSemantic proximity Read ↗

Longitudinal Cognitive and Biomarker Measurements Support a Unidirectional Pathway in Alzheimer’s Disease PathophysiologySemantic proximity Read ↗

Additive effects of cerebrovascular disease functional connectome phenotype and plasma p-tau181 on longitudinal neurodegeneration and cognitive outcomesSemantic proximity Read ↗

Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkersSemantic proximity Read ↗

Biomarker Variability Limits Individualized Amyloid Time Estimation in Alzheimer DiseaseSemantic proximity Read ↗

Clinical and Pathological Progression of Awareness Trajectories in Preclinical Alzheimer’s DiseaseSemantic proximity Read ↗

Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without DementiaSemantic proximity Read ↗

Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer’s DiseaseSemantic proximity Read ↗

Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onsetSemantic proximity Read ↗

Cardiovascular risk and hippocampal-cognitive coupling in Alzheimer’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.